---
checkpoint_id: "CP8-CR163-TRIAL-LINEAGE-INSTRUMENTATION-RELEASE-READINESS"
checkpoint_name: "CR163 Release Readiness"
type: "auto_then_manual"
status: "approved"
owner: "host-orchestrator"
created_at: "2026-07-11T16:20:00+08:00"
reviewed_at: "2026-07-11T16:13:44+08:00"
reviewed_by: "user"
change_id: "CR-163"
release_decision: "READY_WITH_RISK"
release_context_ref: "process/release/RELEASE-CONTEXT-CR163-TRIAL-LINEAGE-INSTRUMENTATION.yaml"
context_ref: "process/context/CP8-CR163-TRIAL-LINEAGE-INSTRUMENTATION-CONTEXT.yaml"
auto_check_result: "process/checks/CP8-CR163-TRIAL-LINEAGE-INSTRUMENTATION-RELEASE-READINESS.result.json"
---

# CP8 CR163 Release Readiness

## 自动预检摘要

| 项目 | 结论 | 量化证据 |
|---|---|---|
| 5 个 Story CP7 | PASS / PASS_WITH_RISK | S01 PASS；S02-S05 PASS_WITH_RISK；open blocker=0 |
| 代码与回归 | PASS | full packet 262 passed；admission subset 220 passed |
| 权限与历史边界 | PASS | 13/13 concrete guards；13/13 observed zero；CR155 backfill/reconstruction=0 |
| 文档 | PASS | docs quality 61 passed；entrypoint check passed |
| Release context | READY_WITH_RISK | compact；fact_diff=10；missing required evidence=0；NOT_EXECUTED |

## Decision Brief

CR-163 已完成“把 trial_count 从事后声明变成过程中自动记录的事实”的阶段目标：未来被正式接入 instrumentation 的运行，可在 pre-search family declaration、完整 append-only trial/attempt/selection 事实、immutable deterministic seal 和 validator 全部通过后产生 `ExperimentFamilyManifest=present`。未接入路径仍为 `typed_unavailable`，不完整、矛盾或篡改 lineage 为 `blocked`。

推荐决策：`approve`，以 `READY_WITH_RISK` 关闭 CR-163。本结论不是 `RELEASED`，也不授权任何真实运行、数据访问、发布或推送。

### 待人工决策

| 决策 ID | 问题 | 推荐方案 | 备选 / 拒绝影响 |
|---|---|---|---|
| `DQ-CP8-CR163-001` | 是否接受 5 个 Story 的 CP7 结论并以 `READY_WITH_RISK` 完成 CR-163？ | approve；确认当前实现和 fixture/static 验证满足冻结范围。 | 修改则回到对应 Story；reject 则 CR 保持 active。 |
| `DQ-CP8-CR163-002` | 是否接受声明上限：raw lineage 已可信，但 effective trials 与 C1 仍不可计算？ | approve；`effective_trial_count=typed_unavailable`，FU-002 另行启动。 | 若要求本 CR 计算 C1，需回退 CP2/CP3 扩大范围。 |
| `DQ-CP8-CR163-003` | 是否接受两项真实剩余风险及其强制触发器？ | approve；仅接受 no-resume 可用性/重跑成本风险和 future retry-loop 条件性验证覆盖风险；分别由 `FU-CR163-001`、`FU-CR163-004` 约束。 | 若不接受，回退 S02/S03 并在本 CR 内实现 resume 或虚构当前不存在的 retry runner，扩大范围。 |
| `DQ-CP8-CR163-004` | 是否授权当前 source + artifact repositories 成对提交和推送？ | approve paired delivery push；保留 tag/package publish/deploy/runtime/data deny-default。 | 不推送则只关闭本地 CP8，双仓交付状态保持 pending。 |

### Decision Collection Coverage

| 来源 | 扫描状态 | 候选问题数 | 纳入决策数 | 结果 |
|---|---:|---:|---:|---|
| CP7 results / aggregate quality | scanned | 2 | 2 | no-resume 与 future retry coverage 纳入 `DQ-CP8-CR163-003` |
| Release Context / release docs | scanned | 4 | 2 | design boundaries 分流；paired push 纳入 `DQ-CP8-CR163-004` |
| 用户 CP8 修订 | scanned | 4 | 4 | 四项 follow-up trigger 全部进入正式 tracking |
| Follow-up tracking / CR index | scanned | 4 | 0 | candidate only，不自动启动 |
| Independent meta-qa-critical audit | scanned | 0 | 0 | 2/2 risks、3/3 boundaries、4/4 triggers PASS |

### 风险、边界与过程状态

真实 accepted risks 仅两项：

1. **No-resume availability/cost risk**：malformed/partial family 不原地 resume，长任务可能损失进度并 full rerun；seal/hash/validator 仍保证错误 evidence 不会成为 `present`。在首个 non-fixture 或 long-running instrumented run 获批前，必须完成 `FU-CR163-001`，或由该 run 的 CR 量化并接受有界重跑损失。
2. **Future retry-loop conditional coverage risk**：当前两个 producer 没有 retry loop，合同和单元语义已通过；若任何 producer 引入 retry loop，同一个 CR 必须在 CP7 和 lineage-present eligibility 前完成 `FU-CR163-004` 的真实 producer ordinal E2E fixture。

以下是设计或范围边界，不作为当前风险：

- Cooperative writer model：出现 multi-process/multi-host/non-cooperative writer 需求前触发 `FU-CR163-002`；当前 correctness 由 seal/hash/validator 保护。
- Exact 10,000 trials：只是 characterization；首次声明支持 `>10k` 或 production SLO/SLA 前触发 `FU-CR163-003`。
- Effective trials/C1：保持 scope ceiling，仅引用既有 `FU-CR161-002`。

过程状态：source 与 artifact repositories 的 paired commit/push 已由用户明确授权，执行证据必须在本轮结束前记录；这不是 residual product risk。

### CP8 后续跟踪分流表

| ID | 分类 | 状态 | 强制触发点 | 台账 |
|---|---|---|---|---|
| `FU-CR163-001` | resume implementation | candidate | 首个 non-fixture/long-running instrumented run 获批前 | `process/changes/CR-163-FOLLOW-UP-TRACKING-2026-07-11.md` |
| `FU-CR163-002` | writer architecture | candidate | multi-process/multi-host/non-cooperative writer requirement 获批前 | 同上 |
| `FU-CR163-003` | capacity/SLO evidence | candidate | `>10k` support 或 production SLO/SLA 声明前 | 同上 |
| `FU-CR163-004` | retry-loop E2E fixture | candidate | 引入 retry loop 的同一 CR 到达 CP7/present eligibility 前 | 同上 |
| `FU-CR161-002` | effective/C1 computation | existing candidate | 独立统计方法 CR 启动时 | `process/changes/CR-161-FOLLOW-UP-TRACKING-2026-07-10.md` |

### 明确不授权

- 真实 research runtime、真实 lake/NAS/provider/credential 操作；
- simulation、paper、live、broker 或交易；
- CR155 reconstruction/backfill；
- effective trials、FDR/PBO/DSR 等统计计算；
- commit、push、tag、publish、deploy 或真实 release execution。

## Entry Criteria

| 条目 | 状态 | 证据 |
|---|---|---|
| CP5 已批准 | PASS | `process/checkpoints/CP5-CR163-ALL-STORIES-LLD-BATCH.md` |
| 5 个 Story CP6/CP7 完成 | PASS | `process/checks/CP6-CR163-*`、`process/checks/CP7-CR163-*` |
| 独立 meta-qa-critical 完成 | PASS | Story CP7 returns/evidence 与 dispatch ledger |
| Release context 存在 | PASS | `process/release/RELEASE-CONTEXT-CR163-TRIAL-LINEAGE-INSTRUMENTATION.yaml` |
| CP8 context capsule 存在 | PASS | `process/context/CP8-CR163-TRIAL-LINEAGE-INSTRUMENTATION-CONTEXT.yaml` |

## Checklist

| # | 检查项 | 结果 | 说明 |
|---|---|---|---|
| 1 | Future instrumented family can produce validated `present` | PASS | 未接入仍 typed_unavailable；非法 evidence blocked |
| 2 | raw count is system fact, not manual provenance | PASS | manual count 仅 reconciliation，不产生 present |
| 3 | append-only / deterministic seal / tamper / supersession | PASS_WITH_RISK | 正确性通过；no-resume 仅为 availability/cost risk，`FU-CR163-001` 有强制 trigger |
| 4 | 2 producer chains / 4 mappings | PASS_WITH_RISK | 当前实现通过；future retry-loop 由同 CR 强制 `FU-CR163-004` |
| 5 | 3 existing consumers fail closed | PASS_WITH_RISK | 不创建平行 gate；effective/C1 仍 blocked |
| 6 | CR155 negative regression | PASS | blocked；paper_candidate=false；backfill/reconstruction=0 |
| 7 | Forbidden operations | PASS | 13/13 concrete boundary guards 与 negative hits |
| 8 | Release overclaim | PASS | READY_WITH_RISK != RELEASED；runtime/data/push 未授权 |

## Exit Criteria

| 条目 | 状态 | 说明 |
|---|---|---|
| 自动预检通过 | PASS | 0 blocker，0 waiver |
| 人工接受 `READY_WITH_RISK` | 待审查 | 需要用户 exact `approve` |
| 不授权边界明确 | PASS | 真正运行/发布另行授权 |
| 状态与 CR 同步 | 待审查 | approval 后由 Host 执行 status-sync |

## Deliverables

| 交付物 | 路径 | 状态 |
|---|---|---|
| Aggregate verification | `docs/quality/VERIFICATION-REPORT-CR163.md` | ready |
| Aggregate test report | `docs/quality/TEST-REPORT-CR163.md` | ready |
| Review / fixes | `docs/quality/REVIEW-CR163.md`、`docs/quality/FIXES-CR163.md` | ready |
| Release context | `process/release/RELEASE-CONTEXT-CR163-TRIAL-LINEAGE-INSTRUMENTATION.yaml` | ready |
| Release docs | `docs/release/*CR163-TRIAL-LINEAGE-INSTRUMENTATION.md` | ready |
| User docs | `docs/components/MULTIFACTOR-RESEARCH.md`、`docs/components/SCRIPT-ENTRYPOINTS.md`、`docs/USER-MANUAL.md` | ready |

## 人工审查结果

- 结论：`approved / READY_WITH_RISK`
- 审查人：user
- 审查时间：2026-07-11T16:13:44+08:00
- 接受决策：`DQ-CP8-CR163-001`、`DQ-CP8-CR163-002`、`DQ-CP8-CR163-003`、`DQ-CP8-CR163-004`
- 风险接受：仅 `RA-CR163-A` no-resume availability/cost loss 与 `RA-CR163-B` future retry-loop conditional validation coverage。
- 修改意见：补齐 `FU-CR163-001..004` 的 owner、activation trigger、required-before、closure/evidence 和 non-authorization 后批准；cooperative lock、10k、effective/C1 改列设计/范围边界；明确授权 source + artifact repositories 成对提交与推送。
